NCT05865353

Brief Summary

This study aims to design, develop, and evaluate a smart insole to predict the formation of diabetic foot ulcers (DFUs) in diabetic participants at risk of developing them. The study will be conducted in two phases, using mixed-method research and engaging both diabetic participants and NHS clinicians. In Phase 1, the user-centred design of the smart insole will be developed through focus groups and online questionnaires, and a preliminary safety evaluation of the insole will be conducted with healthy team members. In Phase 2, the insole will be tested, validated, and data will be collected through baseline visits, lab studies, and insole data collection with shape-changed (pressure off-loading) insoles. The study will be conducted by researchers from the University of Manchester and the University of Exeter. It will include 10 people with diabetes and 10 healthy controls in Phase 2.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

February 6, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

July 24, 2024

Status Verified

July 1, 2024

Enrollment Period

7 months

First QC Date

February 6, 2023

Last Update Submit

July 23, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Shear data

    Shear data The primary outcome measure includes testing the reliability of the smart insole in collecting 1. Shear stress data (KPa) while walking at a self-selected speed on the treadmill for 15 minutes 2. walking on the floor for 2 minutes. 3. standing on the floor for 5 minutes.

    Participant visit is for 90 minutes and data collection is for the (15 minutes walk, 2 minutes and standing still for 5 minutes)

Study Arms (2)

Diabetes

Ten Diabetic participants at risk of DFU/ in this cross-sectional study, participants will be asked to use the smart insole and complete sitting, standing and walking task

Healthy control

Ten healthy participants without movement disorder or Diabetes. The same tasks (sitting, standing and walking) while wearing the smart insole will be repeated for the control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population comprises 20 individuals from both genders, divided into two groups: a Diabetic Group consisting of 10 patients with a confirmed diagnosis of diabetes who are at risk of developing or have a history of diabetic foot ulcer (DFU), and a Healthy Control Group consisting of 10 individuals with no diagnosis of diabetes or movement disorder. The selection criteria for the Diabetic Group include a confirmed diagnosis of diabetes and a history or risk of developing DFU, while the Healthy Control Group includes individuals with no known medical conditions that could affect their movement or balance.

You may qualify if:

  • Confirmed diagnosis of diabetes
  • )At the risk of developing a DFU 2) Able to understand and communicate to safely participate \[Brief Assessment of Capacity 3) to have a score at least 6/8 (UBACC)\]Capacity to participate 4) capability to walk for 10 mins without rest 5) Be able to walk for 30 minutes with no pain, no walking aid, and take breaks if required.
  • \) Must have sensation on their feet 7) Able to walk without a walking aid or orthotic.

You may not qualify if:

  • Below 18 years old
  • Contradictions to walking and physical activity
  • Broken skin on the foot
  • Suffering from a skin condition such as severe eczema or skin allergies
  • Pain affecting the ability to walk.
  • Healthy participants
  • Above 18 years old
  • Able to walk for 30 minutes with no pain, no walking aid, and taking breaks if required.
  • No contraindications to walking and physical activity
  • No broken skin on the foot
  • Do not suffer from a skin condition such as severe eczema or skin allergies.
  • below 18 years old
  • Any movement disorder
  • Pain during the walk
  • Broken skin on the foot.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Exeter

Exeter, EX1 2LU, United Kingdom

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Helen Dawes, PhD

    Professor of Clinical Rehabilitations

    PRINCIPAL INVESTIGATOR
  • Andrew Weightman, PhD

    Professor of Medical Mechatronics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2023

First Posted

May 18, 2023

Study Start

February 1, 2023

Primary Completion

August 30, 2023

Study Completion

September 30, 2023

Last Updated

July 24, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Individual data will not be shared with other researchers or third party

Locations